Literature DB >> 2241200

Dermatitis herpetiformis bodies. Ultrastructural study on the skin of patients using direct preembedding immunogold labeling.

S Kárpáti1, M Meurer, W Stolz, K Schrallhammer, T Krieg, O Braun-Falco.   

Abstract

Skin samples from three adult patients with dermatitis herpetiformis (DH) and granular IgA deposits in the papillary tips were studied using ultrastructural immunogold technique. IgA positive, so-called DH bodies were identified as amorphous clumps--most probably immunocomplex aggregates--scattered throughout the upper papillary dermis. Dermatitis herpetiformis bodies were seen underneath the basement membrane, sometimes along microfibrillar bundles, as well as adjacent to the papillary collagen fibers and within the surface (microfibrillar) region of elastic tissue. Some DH bodies, however, were not related to any fibrillar components. The collagen and elastic fibers, microfibrillar bundles, anchoring fibrils, and elastic microfibrils themselves were unlabeled. Dermatitis herpetiformis bodies were not found in normal human skin. The results of our ultrastructural study indicate that DH bodies either are bound to a nonfibrillar component of dermal connective tissue or represent deposits of immune complexes trapped in DH skin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241200

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  3 in total

Review 1.  [Dermatitis herpetiformis. A clinical chameleon].

Authors:  C Pfeiffer
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

2.  Gene expression profiling in dermatitis herpetiformis skin lesions.

Authors:  M Dolcino; E Cozzani; S Riva; A Parodi; E Tinazzi; C Lunardi; A Puccetti
Journal:  Clin Dev Immunol       Date:  2012-09-06

3.  Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis.

Authors:  Miklós Sárdy; Sarolta Kárpáti; Barbara Merkl; Mats Paulsson; Neil Smyth
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.